LDL Isn’t the Problem? The Real Drivers of Heart Disease

<p>📢 Ask Dr. Bikman’s Digital Mind (multilingual):</p><p><a href="https://benbikman.com/ben-bikmans-digital-ai-mind" rel="noopener noreferrer" target="_blank">https://benbikman.com/ben-bikmans-digital-ai-mind</a></p><br /><p>📢 Dr. Bikman’s Community &amp; Coaching Site: <a href="https://insuliniq.com" rel="noopener noreferrer" target="_blank">https://insuliniq.com</a></p><br /><p><strong>Topic:</strong></p><p>LDL cholesterol is a weak predictor of heart disease compared to markers of insulin resistance, metabolic syndrome, and the triglyceride-to-HDL ratio. True cardiovascular risk is driven far more by metabolic dysfunction than by cholesterol numbers alone.</p><br /><p><strong>Summary:</strong></p><p>In this episode, Ben challenges the long-standing belief that LDL cholesterol is the primary driver of heart disease. While LDL has dominated cardiovascular conversations for decades, large-scale data show that nearly half of people hospitalized with heart disease have “normal” LDL levels.</p><br /><p>Instead, the strongest predictors of cardiovascular risk — especially premature heart disease — are markers of metabolic dysfunction, particularly insulin resistance. Measures like the lipoprotein insulin resistance (LP-IR) score, type 2 diabetes status, metabolic syndrome, and even the simple triglyceride-to-HDL ratio dramatically outperform LDL cholesterol in predicting who will develop heart disease.</p><br /><p>One of the most practical tools discussed is the triglyceride-to-HDL ratio, which can be calculated from a standard lipid panel. This ratio reflects underlying insulin resistance and small, dense LDL particles far better than LDL levels alone.</p><br /><p>Dr. Bikman also reviews the modest benefits of statins in primary prevention and highlights a critical point: lowering LDL does not address the root metabolic dysfunction driving cardiovascular disease. In fact, statin use — particularly in women — may increase the risk of developing type 2 diabetes.</p><br /><p>The takeaway is clear: cardiovascular prevention should shift from being LDL-centric to metabolism-centric. Insulin sensitivity, triglycerides, HDL, fasting insulin, and glycemic control are far more powerful indicators of risk than LDL cholesterol alone.</p><br /><p>References:</p><p>For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&amp;A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: <a href="https://www.benbikman.com" rel="noopener noreferrer" target="_blank">https://www.benbikman.com</a></p><br /><p>NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.</p><br /><p>Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884</p><br /><p>Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb</p><br /><p>Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)</p><hr /><p style="color: grey; font-size: 0.75em;"> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color: grey;" target="_blank">acast.com/privacy</a> for more information.</p>